17.00
price up icon0.10%   0.0175
after-market Dopo l'orario di chiusura: 17.00
loading

Pieris Pharmaceuticals Inc Azioni (PIRS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
95.92%
0.053
1.299 19.52 20.05 1.936
Operating Expenses
7.66%
5.356
5.80 31.33 17.99 17.45
Benefits Costs and Expenses
100.00%
-
67.35 - - -
Costs And Expenses
810.88%
5.356
0.588 31.33 17.99 17.45
Operating Income/Loss
17.82%
-5.303
-4.501 -11.81 2.063 -15.51
Income/Loss From Continuing Operations Before Tax
100.08%
0.053
-66.06 19.52 20.05 1.936
Income/Loss From Continuing Operations After Tax
6.70%
-4.892
-4.585 -10.75 3.976 -13.18
Net Income/Loss
6.72%
-4.892
-4.584 -10.75 3.976 -13.18
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
58.36%
1.237
2.971 98.85 87.64 74.52
Basic Earnings Per Share
9,775%
-3.95
-0.04 -0.11 0.05 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):